Switching from treatment with fresh frozen plasma (FFP) to Adzynma (ADAMTS13, recombinant-krhn) can help people with congenital thrombotic thrombocytopenic…
Articles by Marisa Wexler MS
Star Therapeutics has raised $125 million to support the development of VGA039, a treatment for von Willebrand disease…
Combining low-dose eltrombopag with reduced-dose prednisone may be an effective approach for controlling immune thrombocytopenia (ITP) while minimizing the…
People with immune thrombocytopenia (ITP) who have had their spleens surgically removed may face an increased risk of clotting…
Adding Cyklokapron (tranexamic acid) to Vonvendi (recombinant von Willebrand factor) does not appear to reduce blood loss following childbirth for…
Casi Pharmaceuticals has been given the all-clear to start dosing a fifth group of patients in a clinical trial…
The U.S. Food and Drug Administration (FDA) has expanded its approval of Vonvendi (recombinant von Willebrand factor), a treatment for…
Using both corticosteroids and plasma exchange therapy — each a standard treatment for acquired thrombotic thrombocytopenic purpura (TTP) —…
The congenital form of thrombotic thrombocytopenic purpura (TTP) can look very different in one person than in another, but…
Daratumumab, an injection therapy approved to treat myeloma, may help to control immune thrombocytopenia (ITP) in individuals whose disease…